AMRN

Amarin (AMRN) Reaches Positive Cash Flow Ahead of Schedule Following Global Restructuring

Amarin (AMRN) Reaches Positive Cash Flow Ahead of Schedule Following Global Restructuring

Business Overview Amarin Corporation plc (NASDAQ: AMRN) is a global pharmaceutical company dedicated to reducing the cardiovascular disease (CVD) burden…

Amarin Corporation plc (AMRN) Q2 2022 Earnings Call

Amarin Corporation plc (NASDAQ: AMRN) Q2 2022 Earnings Conference

Amarin Corporation plc (AMRN) Q1 2022

Amarin Corporation plc (NASDAQ: AMRN) Q1 2022 Earnings Conference

Amarin Corporation plc (AMRN) Fourth Quarter and Full Year 2021 Financial Results And Host Conference Call on March 1, 2022

Amarin Corporation plc (NASDAQ: AMRN) Q4 2021 Earnings Conference

Amarin Corporation plc (AMRN) AMARIN TO REPORT THIRD QUARTER 2021 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 3, 2021

Amarin Corporation plc (NASDAQ: AMRN) Q3 2021 Earnings Conference

Amarin Corporation plc (AMRN) Q2 2021

Amarin Corporation plc (NASDAQ: AMRN) Q2 2021 Earnings Conference

Amarin Corporation plc (AMRN) Amarin to Report First Quarter Results and Host Conference Call on April 29, 2021

Amarin Corporation plc (NASDAQ: AMRN) Q1 2021 Earnings Conference

Amarin Corporation plc (AMRN) Q3 2020 Earnings Call Transcript

Amarin Corporation plc (NASDAQ: AMRN) Q3 2020 earnings call dated Nov. 05, 2020 Corporate Participants: Elisabeth Schwartz — Senior Director, Investor Relations…

Amarin Corporation plc (AMRN) Q2 2020 Earnings Call Transcript

Amarin Corporation plc (NASDAQ: AMRN) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Elisabeth Schwartz — Senior Director of Investor…

Amarin (AMRN) Q2 2020 earnings call: Focus was mainly on VASCEPA litigation

Amarin (NASDAQ: AMRN) reported second quarter 2020 results yesterday. During the earnings conference call, the management and the analysts discussed…